Cellectar biosciences hires dr. andrei shustov as new senior vice president, medical

Florham park, n.j., feb. 15, 2023 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that it has hired andrei shustov, m.d., as its new senior vice president, medical reporting to mr. james caruso, president and ceo. in this role, dr. shustov will lead and provide oversight on all aspects of the company's clinical development program, medical affairs, and medical communications.
CLRB Ratings Summary
CLRB Quant Ranking